Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:
聖地亞哥,2024年5月8日(環球新聞專線)——Travere Therapeutics, Inc.(納斯達克股票代碼:TVTX)今天宣佈,公司管理層將參加以下即將舉行的投資者會議:
BofA Securities Health Care Conference
Wednesday, May 15, 2024, at 8:00 a.m. PT
美銀證券醫療保健會議
太平洋時間 2024 年 5 月 15 日星期三上午 8:00
Jefferies Global Healthcare Conference
Wednesday, June 5, 2024, at 3:00 p.m. ET
傑富瑞全球醫療保健會議
美國東部時間 2024 年 6 月 5 日星期三下午 3:00
Live webcasts of the presentations will be accessible on the Investor page of Travere's website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.
演講的網絡直播可在特拉弗雷網站的投資者頁面ir.travere.com/events-presents-presents上觀看。重播將在每場賽事結束後的30天內開放。
About Travere Therapeutics
關於特拉弗療法
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
在Travere Therapeutics,我們處於生命中罕見的境地。我們是一家生物製藥公司,每天齊心協力,幫助不同背景的患者、家屬和護理人員應對罕見疾病的生活。在這條道路上,我們知道迫切需要治療方案,這就是爲什麼我們的全球團隊與罕見病界合作,確定、開發和提供改變生活的療法。爲了實現這一使命,我們不斷尋求了解罕見患者的不同視角,勇敢地開闢新的道路,改變他們的生活,爲他們帶來希望,無論是今天還是未來。欲了解更多信息,請訪問 travere.com。
Contact Info
聯繫信息
Media: 888-969-7879 mediarelations@travere.com |
Investors: 888-969-7879 IR@travere.com |
媒體: 888-969-7879 mediarelations@travere.com |
投資者: 888-969-7879 IR@travere.com |
譯文內容由第三人軟體翻譯。